Efficacy of Combination Chemo-Immunotherapy as a First-Line Treatment for Advanced Non-Small-Cell Lung Cancer Patients With HER2 Alterations: A Case Series. The gene discussed is ERBB2; the disease is non-small cell lung carcinoma.